Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01793545 · ClinicalTrials.gov registry record
Endometrial Cancer Testing With Vaginal and Endometrial Cell Samples
A clinical trial of Endometrial Cancer and Gynecological Cancers, sponsored by National Cancer Institute (NCI).
- Completed
- Registry status
- 1,932
- Enrollment target
- 1
- Study location
NCT01793545 is a study of Endometrial Cancer and Gynecological Cancers that has completed, run by National Cancer Institute (NCI). The registered enrollment target is 1,932 participants, above the 513-participant average among 181 other Endometrial Cancer trials with a reported enrollment target (277% higher). The trial reports 1 study location across 1 state.
The verdict
NCT01793545, a study of Endometrial Cancer and Gynecological Cancers, has completed, sponsored by National Cancer Institute (NCI).
- COMPLETED
- Registry status
- 1,932 participants
- Enrollment target
- 1
- Study location
Study Summary
Background: \- Endometrial cancer is one of the most common gynecologic cancers. If it is caught at an early stage, it can be treated more easily. Women who have this type of cancer often have a history of irregular menstrual bleeding. They may also have abnormal findings during gynecologic exams. Pap smears and cervical cell collection may be able to collect cell samples for cancer testing. However, samples from the vagina or endometrium may produce more accurate results. Researchers want to collect vaginal and endometrial cell samples to improve their tests for and understanding of endometrial cancer. Objectives: \- To collect vaginal and endometrial cell samples to study endometrial cancer. Eligibility: \- Women at least 18 years of age who have had symptoms of abnormal uterine or post-menopausal bleeding, or abnormal ultrasound findings. Design: * Participants will be screened with a physical exam and medical history. * Participants will have a pelvic exam. Before the exam, they will insert a small tampon in the vagina. The tampon will stay in place for about 10 to 30 minutes. The tampon will then be removed and collected for the study. * During the pelvic exam, tissue will be collected from the uterine lining with a special brush. An additional sample (biopsy) will be collected from the lining. * A blood sample will also be collected as part of the study.
Conditions Studied
Study Locations (1)
Minnesota
- Mayo Clinic, Rochester - Rochester
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,932 participants |
| Start Date | 2013-02-11 |
| Est. Completion | 2020-11-16 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01793545
The ClinicalTrials.gov registry entry for NCT01793545 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 1,932 participants, a figure that helps gauge the scale of data the investigators plan to collect, above the 513-participant average among 181 other Endometrial Cancer trials with a reported enrollment target (277% higher). The listed sponsor is National Cancer Institute (NCI), which has 3,257 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Endometrial Cancer appearing as the primary indexed condition, and to 0 interventions.
NCT01793545 reports 1 study location spanning 1 distinct geographic area - top geographies include Minnesota.
Frequently Asked Questions
What is clinical trial NCT01793545 about?
NCT01793545 is a clinical study titled "Endometrial Cancer Testing With Vaginal and Endometrial Cell Samples". Background: \- Endometrial cancer is one of the most common gynecologic cancers. If it is caught at an early stage, it can be treated more easily. Women who have this type of cancer often have a history of irregular menstrual bleeding. They may also have abnormal findings during gynecologic exams. ...
What is the current status of trial NCT01793545?
This trial is currently completed. The enrollment target is 1,932 participants. The study started on 2013-02-11. Estimated completion is 2020-11-16.
What conditions does trial NCT01793545 study?
This clinical trial studies the following conditions: Endometrial Cancer, Gynecological Cancers.
Who is sponsoring clinical trial NCT01793545?
This trial is sponsored by National Cancer Institute (NCI), which has 3,257 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01793545 being conducted?
This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Endometrial Cancer
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Phase I/IIa Study of AZD5335 as Monotherapy and Combination Therapy in Participants With Solid Tumors
RECRUITING · Phase 1
-
The Better, Harder, Faster, Stronger Study
RECRUITING
-
A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors
RECRUITING · Phase 1
-
Study of AVZO-021 in Patients With Advanced Solid Tumors
RECRUITING · Phase 1
-
A Phase I/IIa Study of AZD8205 Given Alone or Combined, in Participants With Advanced/Metastatic Solid Malignancies
RECRUITING · Phase 1
-
A Study of Targeted Agents for Patients With Recurrent or Persistent Endometrial Cancer
RECRUITING · Phase 1
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.